BSEBoard Meeting27 Oct 2026 · 27 Oct 2026, 12:24 pm
Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve un-audited standalone and consolidated financial results for the quarter and half year ended 30.09.2026
Gujarat Themis Biosyn Ltd · 506879
✦ AI SummaryResults
Gujarat Themis Biosyn Ltd has scheduled a Board Meeting on 04/11/2026 to consider and approve un-audited standalone and consolidated financial results for the quarter and half year ended 30.09.2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gujarat Themis Biosyn Ltd - 506879 - Board Meeting Intimation for Consideration And Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30.09.2026
Attachments (1)
📄pdf
Download →
2da88c3b-9540-441b-82e1-d6281310e9a7.pdf
View document text
GUJARAT THEMIS
BIOSYN LIMITED
CIN: L24230GJ1981PLC004878
REGD. OFFICE &FACTORY: 69/C GIDC INDUSTRIAL ESTATE,
VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA
TEL: 0260-2430027 / 2400639
E-mail:hrm@gtbl.in.net
GTBL/BSE/NSE/2026-27/73 27th October, 2026
Listing Department Department of Corporate Services
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, C-1, Block-G Phiroze Jeejeebhoy Towers, Dalal Street
Bandra Kurla Complex Mumbai 400001
Bandra East, Mumbai 400051
Symbol: GUJTHEM Scrip Code: 506879
Dear Sir / Madam,
Sub: Intimation of date of Board meeting of the Company under Regulation 29 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015:
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, we hereby inform you that a meeting of the Board of Directors of Gujarat Themis Biosyn Limited is
scheduled to be held on Wednesday, 4th November, 2026 to consider and approve the Un-Audited
Standalone and Consolidated Financial Results for the quarter and half year ended on 30th September, 2026
and Limited Review Reports of the Auditor thereon;
Further, we would like to inform you that as per the Company’s Code of Conduct for Prevention of Insider
Trading pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company had
intimated its ‘Designated Persons’ that the Trading Window would remain closed from 01st October, 2026
till the expiry of 48 hours from the date of publication of the said financial results of the Company.
This is for your information and record please.
Thanking you,
Yours faithfully,
For Gujarat Themis Biosyn Limited
Vineet Gawankar
Company Secretary & Compliance Officer
MUMBAI OFFICE: Themis House, 11/12 Udyog Nagar, S.V Road, Goregaon (West), Mumbai – 400 104
Tel: 91-22-67607080 / 28757836 Fax: 28746621 / 67607019; E-mail: gtblmumbai@gtbl.in Website Address: www.gtbl.in